InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
3
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-53.1%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Hallam Thomas. Director active across 1 company, notably Palisade Bio, INC.. In total, 3 reports have been published. Breakdown: 3 buys · 0 sell. Total volume traded: €33k. History available since 21 September 2021. The latest transaction was disclosed on 16 August 2022 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Hallam Thomas
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
40,000 shares@ US$0.2521.3% of flowCommon Stock, par value $0.01SEC:0001493152-22-023511:0
Canonical exit: 14 Nov 2022 (T+90)
10,000 shares@ US$1.1832.2% of flowCommon StockSEC:0001209191-22-021405:0
Canonical exit: 26 Jun 2022 (T+90)
6,000 shares@ US$2.4938.3% of flowCommon StockSEC:0001209191-21-057318:0
Canonical exit: 20 Dec 2021 (T+90)
3 of 3 declarations
About Hallam Thomas
Hallam Thomas is a declarant linked to Palisade Bio, INC. on XNAS. The record shows 4 filings in total, and across the 4 sampled recent filings, acquisitions totaling EUR 46054, with no sales, between 2021-09-22 and 2022-08-18.
